The rapid nature of GLP-1-induced weight loss creates unique considerations that differ from traditional weight loss methods
By slowing digestion and signaling fullness to the brain, GLP-1 may play a supporting role in weight management
No, OZEMPIC is only for type 2 diabetes mellitus and should not be used for type 1 diabetes
In addition, subjects on VYVANSE showed greater improvement as compared to placebo across key secondary outcomes with higher proportion of subjects rated improved on the CGI-I rating scale, higher proportion of subjects with 4-week binge cessation, and greater reduction in the Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE) total score
Poor response to GLP-1 therapy with continued weight loss and hyperglycaemia may occasionally indicate misdiagnosed diabetes type
Note: If you do not see a screen that says Congratulations, youve registered, go the main Wacom ID page and select the Register your device option